. 2017 Aug 22;117(5):734-743.

doi: 10.1038/bjc.2017.231. Epub 2017 Aug 1.

Height, selected genetic markers and prostate cancer risk: results from the PRACTICAL consortium

Artitaya Lophatananon^{1

2}, Sarah Stewart-Brown¹, Zsofia Kote-Jarai³, Ali Amin Al Olama⁴, Sara Benlloch Garcia⁴, David E Neal^{5

6}, Freddie C Hamdy⁷, Jenny L Donovan⁸, Graham G Giles^{9

10}, Liesel M Fitzgerald⁹, Melissa C Southey¹¹, Paul Pharoah¹², Nora Pashayan^{12

13}, Henrik Gronberg¹⁴, Fredrik Wiklund¹⁴, Markus Aly^{14

15}, Janet L Stanford^{16

17}, Hermann Brenner^{18

19}, Aida K Dieffenbach^{20

21}, Volker Arndt²⁰, Jong Y Park²¹, Hui-Yi Lin²², Thomas Sellers²¹, Chavdar Slavov²³, Radka Kaneva²⁴, Vanio Mitev²⁴, Jyotsna Batra²⁵, Amanda Spurdle²⁶, Judith A Clements²⁵; APCB BioResource; PRACTICAL consortium; Douglas Easton⁴, Rosalind A Eeles^{3

27}, Kenneth Muir^{1

2}

Collaborators, Affiliations

Collaborators

Johanna Schleutker, BØrge G Nordestgaard, Fredrik Wiklund, Ruth C Travis, Christopher A Haiman, Stephen N Thibodeau, Christiane Maier, Vogel Walther, William J Blot, Adam S Kibel, Cezary Cybulski, Lisa Cannon-Albright, Hardev Pandha, Manuel R Teixeira, Margaret Cook, Koveela Govindasami, Michelle Guy, Daniel Leongamornlert, Emma J Sawyer, Rosemary Wilkinson, Angela Morgan, Cyril Fisher, Edward J Saunders, Malgorzata Tymrakiewicz, Naomi Livni, Steve Hazel, Tokhir Dadaev, Angela Cox, Anne George, Athene Lane, Gemma Marsden, Michael Davis, Paul Brown, John Pedersen, John L Hopper, Ami Karlsson, Carin Cavalli-Bjoerkman, Jan Adolfson, Jan-Erik Johansson, Michael Broms, Paer Stattin, Suzanne Kolb, Christa Stegmaier, Babu Zachariah, Hyun Park, James Haley, Julio Pow-Sang, Maria Rincon, Selina Radlein, Aleksandrina Vlahova, Atanaska Mitkova, Darina Kachakova, Elenko Popov, Svetlana Christova, Tihomir Dikov, Allison Eckert, Angus Collins, Glenn Wood, Greg Malone, Kimberly Alexander, Kris Kerr, Mary-Anne Kedda, Megan Turner, Pamela Saunders, Peter Heathcote, Srilakshmi Srinivasan, Tracy Omara, Trina Yeadon, Felicity Lose

Affiliations

¹ Centre of Epidemiology, Division of Population Health, Health Services Research and Primary Care, School of Health Sciences, Medicine and Health, The University of Manchester, Manchester M13 9PL, UK.
² Division of Health sciences, Warwick Medical School, University of Warwick, Coventry CV4 7AL, UK.
³ Division of Genetics and Epidemiology, The Institute of Cancer Research, London SW7 3RP, UK.
⁴ Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Strangeways Research Laboratory, Cambridge CB1 8RN, UK.
⁵ Nuffield Department of Surgical Sciences, John Radcliffe Hospital, Headington, Oxford OX3 9DU, UK.
⁶ Cancer Research UK Cambridge Research Institute, Li Ka Shing Centre, Cambridge CB2 0RE, UK.
⁷ Nuffield Department of Surgical Sciences John Radcliffe Hospital, University of Oxford, Oxford OX3 9DU, UK.
⁸ School of Social and Community Medicine, University of Bristol, Canynge Hall, 39 Whatley Road, Bristol BS8 2PS, UK.
⁹ Cancer Epidemiology Centre, The Cancer Council Victoria, 615 St Kilda Road, Melbourne, Victoria 3004, Australia.
¹⁰ Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Victoria 3010, Australia.
¹¹ Genetic Epidemiology Laboratory, Department of Pathology, The University of Melbourne, Grattan Street, Parkville, Victoria 3010, Australia.
¹² Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Strangeways Laboratory, Worts Causeway, Cambridge CB1 8RN, UK.
¹³ Department of Applied Health Research, University College London, 1-19 Torrington Place, London WC1E 7HB, UK.
¹⁴ Department of Medical Epidemiology and Biostatistics, Karolinska Institute, Stockholm 10435, Sweden.
¹⁵ Department of Clinical Sciences at Danderyds Hospital, Stockholm 17177, Sweden.
¹⁶ Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, WA 98109-1024, USA.
¹⁷ Department of Epidemiology, School of Public Health, University of Washington, Seattle, WA 98195, USA.
¹⁸ Division of Clinical Epidemiology and Aging Research, German Cancer Research Center (DKFZ), Heidelberg 69120, Germany.
¹⁹ Division of Preventive Oncology, German Cancer Research Center (DKFZ), Heidelberg 69120, Germany.
²⁰ German Cancer Consortium (DKTK), Heidelberg 69120, Germany.
²¹ Department of Cancer Epidemiology, Moffitt Cancer Center, 12902 Magnolia Drive, Tampa, FL 33612, USA.
²² Biostatistics Program, Moffitt Cancer Center, 12902 Magnolia Drive, Tampa, FL 33612, USA.
²³ Department of Urology and Alexandrovska University Hospital, Medical University, Sofia 1431, Bulgaria.
²⁴ Department of Medical Chemistry and Biochemistry, Molecular Medicine Center, Medical University, Sofia, 2 Zdrave Str., Sofia 1431, Bulgaria.
²⁵ Australian Prostate Cancer Research Centre-Qld, Institute of Health and Biomedical Innovation and School of Biomedical Science, Queensland University of Technology, Brisbane 4006, Australia.
²⁶ Molecular Cancer Epidemiology Laboratory, Queensland Institute of Medical Research, Brisbane 4006, Australia.
²⁷ Royal Marsden National Health Service (NHS) Foundation Trust, London and Sutton SM2 5PT, UK.

PMID: 28765617
PMCID: PMC5572182
DOI: 10.1038/bjc.2017.231

Height, selected genetic markers and prostate cancer risk: results from the PRACTICAL consortium

Artitaya Lophatananon et al. Br J Cancer. 2017.

. 2017 Aug 22;117(5):734-743.

doi: 10.1038/bjc.2017.231. Epub 2017 Aug 1.

Authors

Collaborators

Johanna Schleutker, BØrge G Nordestgaard, Fredrik Wiklund, Ruth C Travis, Christopher A Haiman, Stephen N Thibodeau, Christiane Maier, Vogel Walther, William J Blot, Adam S Kibel, Cezary Cybulski, Lisa Cannon-Albright, Hardev Pandha, Manuel R Teixeira, Margaret Cook, Koveela Govindasami, Michelle Guy, Daniel Leongamornlert, Emma J Sawyer, Rosemary Wilkinson, Angela Morgan, Cyril Fisher, Edward J Saunders, Malgorzata Tymrakiewicz, Naomi Livni, Steve Hazel, Tokhir Dadaev, Angela Cox, Anne George, Athene Lane, Gemma Marsden, Michael Davis, Paul Brown, John Pedersen, John L Hopper, Ami Karlsson, Carin Cavalli-Bjoerkman, Jan Adolfson, Jan-Erik Johansson, Michael Broms, Paer Stattin, Suzanne Kolb, Christa Stegmaier, Babu Zachariah, Hyun Park, James Haley, Julio Pow-Sang, Maria Rincon, Selina Radlein, Aleksandrina Vlahova, Atanaska Mitkova, Darina Kachakova, Elenko Popov, Svetlana Christova, Tihomir Dikov, Allison Eckert, Angus Collins, Glenn Wood, Greg Malone, Kimberly Alexander, Kris Kerr, Mary-Anne Kedda, Megan Turner, Pamela Saunders, Peter Heathcote, Srilakshmi Srinivasan, Tracy Omara, Trina Yeadon, Felicity Lose

Affiliations

¹ Centre of Epidemiology, Division of Population Health, Health Services Research and Primary Care, School of Health Sciences, Medicine and Health, The University of Manchester, Manchester M13 9PL, UK.
² Division of Health sciences, Warwick Medical School, University of Warwick, Coventry CV4 7AL, UK.
³ Division of Genetics and Epidemiology, The Institute of Cancer Research, London SW7 3RP, UK.
⁴ Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Strangeways Research Laboratory, Cambridge CB1 8RN, UK.
⁵ Nuffield Department of Surgical Sciences, John Radcliffe Hospital, Headington, Oxford OX3 9DU, UK.
⁶ Cancer Research UK Cambridge Research Institute, Li Ka Shing Centre, Cambridge CB2 0RE, UK.
⁷ Nuffield Department of Surgical Sciences John Radcliffe Hospital, University of Oxford, Oxford OX3 9DU, UK.
⁸ School of Social and Community Medicine, University of Bristol, Canynge Hall, 39 Whatley Road, Bristol BS8 2PS, UK.
⁹ Cancer Epidemiology Centre, The Cancer Council Victoria, 615 St Kilda Road, Melbourne, Victoria 3004, Australia.
¹⁰ Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Victoria 3010, Australia.
¹¹ Genetic Epidemiology Laboratory, Department of Pathology, The University of Melbourne, Grattan Street, Parkville, Victoria 3010, Australia.
¹² Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Strangeways Laboratory, Worts Causeway, Cambridge CB1 8RN, UK.
¹³ Department of Applied Health Research, University College London, 1-19 Torrington Place, London WC1E 7HB, UK.
¹⁴ Department of Medical Epidemiology and Biostatistics, Karolinska Institute, Stockholm 10435, Sweden.
¹⁵ Department of Clinical Sciences at Danderyds Hospital, Stockholm 17177, Sweden.
¹⁶ Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, WA 98109-1024, USA.
¹⁷ Department of Epidemiology, School of Public Health, University of Washington, Seattle, WA 98195, USA.
¹⁸ Division of Clinical Epidemiology and Aging Research, German Cancer Research Center (DKFZ), Heidelberg 69120, Germany.
¹⁹ Division of Preventive Oncology, German Cancer Research Center (DKFZ), Heidelberg 69120, Germany.
²⁰ German Cancer Consortium (DKTK), Heidelberg 69120, Germany.
²¹ Department of Cancer Epidemiology, Moffitt Cancer Center, 12902 Magnolia Drive, Tampa, FL 33612, USA.
²² Biostatistics Program, Moffitt Cancer Center, 12902 Magnolia Drive, Tampa, FL 33612, USA.
²³ Department of Urology and Alexandrovska University Hospital, Medical University, Sofia 1431, Bulgaria.
²⁴ Department of Medical Chemistry and Biochemistry, Molecular Medicine Center, Medical University, Sofia, 2 Zdrave Str., Sofia 1431, Bulgaria.
²⁵ Australian Prostate Cancer Research Centre-Qld, Institute of Health and Biomedical Innovation and School of Biomedical Science, Queensland University of Technology, Brisbane 4006, Australia.
²⁶ Molecular Cancer Epidemiology Laboratory, Queensland Institute of Medical Research, Brisbane 4006, Australia.
²⁷ Royal Marsden National Health Service (NHS) Foundation Trust, London and Sutton SM2 5PT, UK.

PMID: 28765617
PMCID: PMC5572182
DOI: 10.1038/bjc.2017.231

Erratum in

Height, selected genetic markers and prostate cancer risk: results from the PRACTICAL consortium.
Lophatananon A, Stewart-Brown S, Kote-Jarai Z, Al Olama AA, Garcia SB, Neal DE, Hamdy FC, Donovan JL, Giles GG, Fitzgerald LM, Southey MC, Pharoah P, Pashayan N, Gronberg H, Wiklund F, Aly M, Stanford JL, Brenner H, Dieffenbach AK, Arndt V, Park JY, Lin HY, Sellers T, Slavov C, Kaneva R, Mitev V, Batra J, Spurdle A, Clements JA; APCB BioResource; PRACTICAL consortium; Easton D, Eeles RA, Muir K. Lophatananon A, et al. Br J Cancer. 2018 Mar 20;118(6):e16. doi: 10.1038/bjc.2018.6. Epub 2018 Feb 13. Br J Cancer. 2018. PMID: 29438364 Free PMC article.

Abstract

Background: Evidence on height and prostate cancer risk is mixed, however, recent studies with large data sets support a possible role for its association with the risk of aggressive prostate cancer.

Methods: We analysed data from the PRACTICAL consortium consisting of 6207 prostate cancer cases and 6016 controls and a subset of high grade cases (2480 cases). We explored height, polymorphisms in genes related to growth processes as main effects and their possible interactions.

Results: The results suggest that height is associated with high-grade prostate cancer risk. Men with height >180 cm are at a 22% increased risk as compared to men with height <173 cm (OR 1.22, 95% CI 1.01-1.48). Genetic variants in the growth pathway gene showed an association with prostate cancer risk. The aggregate scores of the selected variants identified a significantly increased risk of overall prostate cancer and high-grade prostate cancer by 13% and 15%, respectively, in the highest score group as compared to lowest score group.

Conclusions: There was no evidence of gene-environment interaction between height and the selected candidate SNPs.Our findings suggest a role of height in high-grade prostate cancer. The effect of genetic variants in the genes related to growth is seen in all cases and high-grade prostate cancer. There is no interaction between these two exposures.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

**Figure 1**
**Forest plot (all prostate cancer cases).**

**Figure 2**
**Forest plot (high grade cases).**

See this image and copyright information in PMC

References

1. Al Olama AA, Kote-Jarai Z, Berndt SI, Conti DV, Schumacher F, Han Y, Benlloch S, Hazelett DJ, Wang Z, Saunders E, Leongamornlert D, Lindstrom S, Jugurnauth-Little S, Dadaev T, Tymrakiewicz M, Stram DO, Rand K, Wan P, Stram A, Sheng X, Pooler LC, Park K, Xia L, Tyrer J, Kolonel LN, Le Marchand L, Hoover RN, Machiela MJ, Yeager M, Burdette L, Chung CC, Hutchinson A, Yu K, Goh C, Ahmed M, Govindasami K, Guy M, Tammela TL, Auvinen A, Wahlfors T, Schleutker J, Visakorpi T, Leinonen KA, Xu J, Aly M, Donovan J, Travis RC, Key TJ, Siddiq A, Canzian F, Khaw KT, Takahashi A, Kubo M, Pharoah P, Pashayan N, Weischer M, Nordestgaard BG, Nielsen SF, Klarskov P, Roder MA, Iversen P, Thibodeau SN, McDonnell SK, Schaid DJ, Stanford JL, Kolb S, Holt S, Knudsen B, Coll AH, Gapstur SM, Diver WR, Stevens VL, Maier C, Luedeke M, Herkommer K, Rinckleb AE, Strom SS, Pettaway C, Yeboah ED, Tettey Y, Biritwum RB, Adjei AA, Tay E, Truelove A, Niwa S, Chokkalingam AP, Cannon-Albright L, Cybulski C, Wokolorczyk D, Kluzniak W, Park J, Sellers T, Lin HY, Isaacs WB, Partin AW, Brenner H, Dieffenbach AK, Stegmaier C, Chen C, Giovannucci EL, Ma J, Stampfer M, Penney KL, Mucci L, John EM, Ingles SA, Kittles RA, Murphy AB, Pandha H, Michael A, Kierzek AM, Blot W, Signorello LB, Zheng W, Albanes D, Virtamo J, Weinstein S, Nemesure B, Carpten J, Leske C, Wu SY, Hennis A, Kibel AS, Rybicki BA, Neslund-Dudas C, Hsing AW, Chu L, Goodman PJ, Klein EA, Zheng SL, Batra J, Clements J, Spurdle A, Teixeira MR, Paulo P, Maia S, Slavov C, Kaneva R, Mitev V, Witte JS, Casey G, Gillanders EM, Seminara D, Riboli E, Hamdy FC, Coetzee GA, Li Q, Freedman ML, Hunter DJ, Muir K, Gronberg H, Neal DE, Southey M, Giles GG, Severi G, Cook MB, Nakagawa H, Wiklund F, Kraft P, Chanock SJ, Henderson BE, Easton DF, Eeles RA, Haiman CA (2014) A meta-analysis of 87,040 individuals identifies 23 new susceptibility loci for prostate cancer. Nat Genet 46: 1103–1109. - PMC - PubMed
1. Al Olama AA, Kote-Jarai Z, Giles GG, Guy M, Morrison J, Severi G, Leongamornlert DA, Tymrakiewicz M, Jhavar S, Saunders E, Hopper JL, Southey MC, Muir KR, English DR, Dearnaley DP, Ardern-Jones AT, Hall AL, O’Brien LT, Wilkinson RA, Sawyer E, Lophatananon A, Horwich A, Huddart RA, Khoo VS, Parker CC, Woodhouse CJ, Thompson A, Christmas T, Ogden C, Cooper C, Donovan JL, Hamdy FC, Neal DE, Eeles RA, Easton DF (2009) Multiple loci on 8q24 associated with prostate cancer susceptibility. Nat Genet 41: 1058–1060. - PubMed
1. Al Olama AA, Kote-Jarai Z, Schumacher FR, Wiklund F, Berndt SI, Benlloch S, Giles GG, Severi G, Neal DE, Hamdy FC, Donovan JL, Hunter DJ, Henderson BE, Thun MJ, Gaziano M, Giovannucci EL, Siddiq A, Travis RC, Cox DG, Canzian F, Riboli E, Key TJ, Andriole G, Albanes D, Hayes RB, Schleutker J, Auvinen A, Tammela TL, Weischer M, Stanford JL, Ostrander EA, Cybulski C, Lubinski J, Thibodeau SN, Schaid DJ, Sorensen KD, Batra J, Clements JA, Chambers S, Aitken J, Gardiner RA, Maier C, Vogel W, Dork T, Brenner H, Habuchi T, Ingles S, John EM, Dickinson JL, Cannon-Albright L, Teixeira MR, Kaneva R, Zhang HW, Lu YJ, Park JY, Cooney KA, Muir KR, Leongamornlert DA, Saunders E, Tymrakiewicz M, Mahmud N, Guy M, Govindasami K, O’Brien LT, Wilkinson RA, Hall AL, Sawyer EJ, Dadaev T, Morrison J, Dearnaley DP, Horwich A, Huddart RA, Khoo VS, Parker CC, Van As N, Woodhouse CJ, Thompson A, Dudderidge T, Ogden C, Cooper CS, Lophatonanon A, Southey MC, Hopper JL, English D, Virtamo J, Le Marchand L, Campa D, Kaaks R, Lindstrom S, Diver WR, Gapstur S, Yeager M, Cox A, Stern MC, Corral R, Aly M, Isaacs W, Adolfsson J, Xu J, Zheng SL, Wahlfors T, Taari K, Kujala P, Klarskov P, Nordestgaard BG, Roder MA, Frikke-Schmidt R, Bojesen SE, Fitzgerald LM, Kolb S, Kwon EM, Karyadi DM, Orntoft TF, Borre M, Rinckleb A, Luedeke M, Herkommer K, Meyer A, Serth J, Marthick JR, Patterson B, Wokolorczyk D, Spurdle A, Lose F, McDonnell SK, Joshi AD, Shahabi A, Pinto P, Santos J, Ray A, Sellers TA, Lin HY, Stephenson RA, Teerlink C, Muller H, Rothenbacher D, Tsuchiya N, Narita S, Cao GW, Slavov C, Mitev V, Chanock S, Gronberg H, Haiman CA, Kraft P, Easton DF, Eeles RA (2012) A meta-analysis of genome-wide association studies to identify prostate cancer susceptibility loci associated with aggressive and non-aggressive disease. Hum Mol Genet 22(2): 408–415. - PMC - PubMed
1. Calle EE (2000) Invited Commentary: Do Anthropometric Measures Predict risk of prostate cancer? Am J Epidemiol 151: 550–553. - PubMed
1. Cao Y, Lindstrom S, Schumacher F, Stevens VL, Albanes D, Berndt S, Boeing H, Bueno-de-Mesquita HB, Canzian F, Chamosa S, Chanock SJ, Diver WR, Gapstur SM, Gaziano JM, Giovannucci EL, Haiman CA, Henderson B, Johansson M, Le Marchand L, Palli D, Rosner B, Siddiq A, Stampfer M, Stram DO, Tamimi R, Travis RC, Trichopoulos D, Willett WC, Yeager M, Kraft P, Hsing AW, Pollak M, Lin X, Ma J (2014) Insulin-like growth factor pathway genetic polymorphisms, circulating IGF1 and IGFBP3, and prostate cancer survival. J Natl Cancer Inst 106: dju085. - PMC - PubMed

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Grants and funding

LinkOut - more resources

Full Text Sources
Other Literature Sources
- scite Smart Citations
Medical
- MedlinePlus Health Information

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Height, selected genetic markers and prostate cancer risk: results from the PRACTICAL consortium

Collaborators

Affiliations

Height, selected genetic markers and prostate cancer risk: results from the PRACTICAL consortium

Authors

Collaborators

Affiliations

Erratum in

Abstract

Conflict of interest statement

Figures

References

MeSH terms

Grants and funding

LinkOut - more resources

Full Text Sources

Other Literature Sources

Medical